PPAR-γ regulates pharmacological but not physiological or pathological osteoclast formation.
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
Wei
W
Zou
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
Nidhi
N
Rohatgi
Department of Orthopaedic Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
Timothy Hung-Po
TH
Chen
Department of Medicine, Division of Cardiology, Washington University School of Medicine, St. Louis, Missouri, USA.
Joel
J
Schilling
Department of Orthopaedic Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
Yousef
Y
Abu-Amer
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.|Department of Medicine, Division of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, Missouri, USA.
Steven L
0000-0002-4054-6679
SL
Teitelbaum
D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005434:Flow Cytometry; D050723:Fractures, Bone / Q000453:epidemiology*; D055785:Gene Knockdown Techniques; D006801:Humans; D016173:Macrophage Colony-Stimulating Factor / Q000494:pharmacology; D051379:Mice; D010010:Osteoclasts / Q000187:drug effects; D010012:Osteogenesis / Q000187:drug effects*; D047495:PPAR gamma / Q000819:agonists* / Q000235:genetics; D053245:RANK Ligand / Q000494:pharmacology; D045162:Thiazolidinediones / Q000494:pharmacology* / Q000627:therapeutic use
D047495:PPAR gamma; D053245:RANK Ligand; D045162:Thiazolidinediones; D016173:Macrophage Colony-Stimulating Factor